Jalandhar Online

Urinary Obstruction Treatment Devices Market

The Global Urinary Tract Obstruction Treatment Devices Market growing at a CAGR of 4.2% during the forecast period from 2022 to 2027.

The Urinary Tract Obstruction Treatment Devices market is witnessing positive growth owing to the growing cases of urological disorders such as bladder cancers, Benign Prostatic Hyperplasia, urolithiasis, or nephrolithiasis, among others. In addition, sedentary lifestyle such as obesity which is a risk factor, innovation in product design, rising old age population across the globe, increase in the number of surgical procedures is thereby contributing to the growth of the Urinary Tract Obstruction Treatment Devices market during the forecast period from 2022-2027.

Some of the key market players operating in the Urinary Tract Obstruction Treatment Devices market include B. Braun Melsungen AG, Boston Scientific Corporation (NYSE: BSX), Cook, Becton, Dickinson, and Company, Teleflex Incorporated (NYSE: TFX), Olympus (OCPNY), Dornier Medtech, EMS Urology, Advin Health Care, Inceler Medikal Co. Ltd., STORZ MEDICAL AG, Shockwave Medical Inc. (NASDAQ: SWAV), ACE Medical Devices Pvt. Ltd., Walz Elektronik GmbH, Applied Medical Resources Corporation, Richard Wolf GmbH, Stryker (NYSE: SYK), Urocare Products, Inc., J and M Urinary Catheters LLC, Rocamed, and others.

DelveInsight’s “Urinary Tract Obstruction Treatment Devices Market Insight & Forecast” report will offer an in-depth understanding of the Urinary Tract Obstruction Treatment Devices market, further benefiting the competitors or stakeholders operating in the Urinary Tract Obstruction Treatment Devices arena.

Urinary Tract Obstruction Treatment Devices

Urinary Tract Obstruction Treatment Devices are devices used to treat obstruction which occurs in the course of urine from the kidney to the urethra.

Interested to know more about the functioning of Urinary Tract Obstruction Treatment Devices- Visit @ Urinary Tract Obstruction Treatment Devices Operations & Working.

Urinary Tract Obstruction Treatment Devices Market Insights

Among all the regions, North America is expected to account for the largest share of the Global Urinary Tract Obstruction Treatment Devices market during the year 2021. Factors such as the growing cases of urological disorders such as bladder and prostate cancers, urolithiasis, or nephrolithiasis, among others, and increased risk of end-stage renal failure among the population, rising product approvals are expected to aid in the growth of the North America Urinary Tract Obstruction Treatment Devices Market.

In the United States, high prostate cancer cases in the region increase the demand for urinary catheters as it causes difficulties in urination. For instance, as per the American Cancer Society 2021 statistics, about 248,530 new cases of prostate cancer are reported in the same year.

The rising cases of upper tract urothelial carcinoma (UTUC), is also the reason for an increase in the usage of Urinary Tract Obstruction Treatment Devices. For instance, as per the Centers for Disease Control and Prevention (CDC) 2020 data, approximately 17,500 women and 56,000 men suffer from bladder cancer in the US. 

Moreover, according to the Canadian cancer society 2020 data, around 12,200 Canadians were suffering from bladder cancer in the year 2020.

As per the Canadian Urological Association guidelines 2021, globally, the prevalence of urolithiasis is steadily increasing,  and though some regional variability exists, contemporary estimates report up to 10%-12% of men and 7%-8% of women now suffer from nephrolithiasis.

Moreover, according to the US Department of Health and Human Services 2021, end-stage renal disease (ESRD) is a significant public health problem in the United States and a major source of suffering and poor quality of life for those afflicted.

Another factor responsible for the growth of the Urinary Tract Obstruction Treatment Devices market is the launch of new products in the region. For instance, in 2019, Dornier Medtech launched and announced the immediate availability of its new AXIS single-use digital flexible ureteroscope in the US.

Thus, these factors are projected to contribute to the Urinary Tract Obstruction Treatment Devices market during the forecasted period. 

Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region is expected to boost the North America Urinary Tract Obstruction Treatment Devices market during the forecast period.

To read more about why North America is leading the market growth in the Urinary Tract Obstruction Treatment Devices market, get a snapshot of the Urinary Tract Obstruction Treatment Devices market report.

Urinary Tract Obstruction Treatment Devices Market Dynamics

The Urinary Tract Obstruction Treatment Devices market is witnessing a growth in product demand owing to various reasons. The key factor includes the growing cases of urological disorders such as bladder cancers, Benign Prostatic Hyperplasia, urolithiasis, or nephrolithiasis, among others across the globe.

The most common causes of urinary obstruction are calculi, blood clots, tumors, or sloughed papilla. These obstructions present acutely, leading to severe renal colic with flank pain, hematuria, nausea, vomiting, and fever.

As per The Urology Foundation 2022, the incidence of benign prostatic hyperplasia (BPH), was estimated to increase from 50% among men between the ages of 50 and 60 years to 90% for men older than 80 years of age. Some men experience a sudden onset of the inability to pass urine (known as acute retention).

According to the European Association of Urology 2019, the prevalence rates for urinary stones vary from 1% to 20%, and in the countries with a high standard of life such as Canada, Sweden, or the US, renal stones prevalence is significantly high (>10%).

According to the National Kidney Foundation 2021, over half a million people go to emergency rooms for kidney stone problems every year.

Moreover, a rise in sedentary lifestyle such as excessive consumption of alcohol, and less consumption of water can also lead to the development of kidney stones. In addition, the growing burden of obesity among the population, a higher risk factor for the development of renal calculi, due to sedentary lifestyles such as poor dietary habits and lack of physical activities will also contribute to the Urinary Tract Obstruction Treatment Devices market growth.

As per the World Health Organization (WHO) 2021 data, there was around 650 million obese population worldwide in the year 2016. Also, according to various studies, obese people develop more uric acid stones and calcium oxalate stones, which further hinder the normal passing of urine from the body.

Also, the aging population is more prone to the risk of end-stage renal failure. As per the World Population Prospects, 2019, there were 703 million older persons aged 65 or over in 2019 globally.  Therefore, as the aging population increases, there will be more prevalence of urolithiasis, which will eventually boost the demand for Urinary Tract Obstruction Treatment Devices which will drive the growth of the Global Urinary Tract Obstruction Treatment Devices market.

However, certain factors such as the high cost of devices and the adverse events may be certain limiting factors to the Urinary Tract Obstruction Treatment Devices market growth.

Covid 19 Impact Analysis

The outbreak of the COVID-19 pandemic caused a significant decrease in emergency department visits. Moreover, there was a delay in outpatient clinic appointments which pushed the need for virtual or telephone clinics. Due to a lack of in-hospital beds, anesthesia or procedural slots, and healthcare professionals, these changes created a significant backlog in the treatment, thereby creating a negative impact on the Global Urinary Tract Obstruction Treatment Devices market.

To discuss the short/long-term impact of COVID-19, get a snapshot of the report Urinary Tract Obstruction Treatment Devices market assessment.

Recent Breakthroughs in Urinary Tract Obstruction Treatment Devices Market:

• In March 2021, Boston Scientific acquired Lumenis in a $1.07 billion deal. With this acquisition, Boston Scientific has strengthened its product portfolio for Lithotripsy devices. This will further add to the growth of the Global Urinary Tract Obstruction Treatment Devices market.
• In March 2021, Dornier MedTech GmbH became the world’s first integrated urology company to be certified by the European Union’s Medical Device Regulation (MDR). Dornier achieved the certification for its Class IIb products:  Dornier Delta® III, one of the most powerful lithotripters that utilize Dornier’s Extracorporeal Shock Wave Lithotripsy (ESWL) technology; and the Dornier UIMS™, a state-of-the-art information management software providing enhanced imaging and efficiency to support clinicians in treating kidney stones.
• In August 2020, Olympus Winter & Ibe GmbH received the US FDA approval for OES Elite Ureteroscopes and Accessories under regulatory class II for endoscopic observation and therapy in the ureters, urethra, and urinary bladder.
• In 2019, Shockwave Medical Inc. received breakthrough device designation for its intravascular lithotripsy (IVL) therapy, used for lithotripsy and was long used to eliminate kidney stones.

Key Players Proactively Working In the Urinary Tract Obstruction Treatment Devices Market

Key Urinary Tract Obstruction Treatment Devices companies involved in manufacturing and production are making significant growth in the advancement of these devices. To boost their market position, they also engage in mergers and acquisitions. Some of the key Urinary Tract Obstruction Treatment Devices companies operating actively in the Urinary Tract Obstruction Treatment Devices market include B. Braun Melsungen AG, Boston Scientific Corporation, Cook, Becton, Dickinson, and Company, Teleflex Incorporated, Olympus, Dornier Medtech, EMS Urology, Advin Health Care, Inceler Medikal Co. Ltd., STORZ MEDICAL AG, Shockwave Medical Inc., ACE Medical Devices Pvt. Ltd., Walz Elektronik GmbH, Applied Medical Resources Corporation, Richard Wolf GmbH, Stryker, Urocare Products, Inc., J and M Urinary Catheters LLC, Rocamed, and others.

Scope of the Urinary Tract Obstruction Treatment Devices Market Report:

• Geography Covered: Global
• Study Period: 2022-2027
• Key Urinary Tract Obstruction Treatment Devices Companies: B. Braun Melsungen AG, Boston Scientific Corporation, Cook, Becton, Dickinson, and Company, Teleflex Incorporated, Olympus, Dornier Medtech, EMS Urology, Advin Health Care, Inceler Medikal Co. Ltd., STORZ MEDICAL AG, Shockwave Medical Inc., ACE Medical Devices Pvt. Ltd., Walz Elektronik GmbH, Applied Medical Resources Corporation, Richard Wolf GmbH, Stryker, Urocare Products, Inc., J and M Urinary Catheters LLC, Rocamed, and others.
• Market Segmentation by Product: Urinary Catheters [Indwelling/Foley Catheters, Intermittent Catheters, External Catheters], Urinary Stents, Shock Wave Lithotripters [Intracorporeal, Extracorporeal], Ureteroscopes [Semi-Rigid, Flexible], Resectoscopes, Stone Retrieval Devices, Laser Therapy Systems, Others), By Indication (Cancers, Stones, Benign Prostatic Hyperplasia (BPH), Hydronephrosis, Others
• Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centers, Others
• Market Segmentation by Geography: North America, Europe, Asia-Pacific, Rest of the World (Middle East, Africa, and South America)
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Table of Contents 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/